![Patrick van Berkel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick van Berkel
No open positions remaining
Profile
Patrick van Berkel currently works at ADC Therapeutics SA, as Chief Scientific Officer.
Dr. van Berkel also formerly worked at Genmab A, as VP-Antibody, Technology & Chemistry from 2003 to 2012.
Dr. van Berkel received his doctorate degree in 1998 from the University of Leiden and undergraduate degree in 1991 from Radboud University Nijmegen.
Former positions of Patrick van Berkel
| Companies | Position | End |
|---|---|---|
| ADC THERAPEUTICS SA | Chief Tech/Sci/R&D Officer | 28/02/2026 |
| GENMAB A/S | Chief Tech/Sci/R&D Officer | 31/12/2011 |
Training of Patrick van Berkel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Radboud University Nijmegen
 Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
- Stock Market
- Insiders
- Patrick van Berkel
